Patient
SITE009-0168
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2026-03-25
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-08-25
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-18 (study day 146); relationship: not assessed
mild
assessed
2026-05-16
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-11-09 (study day 45); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.